Buffett buys J&J as Soros trims Pfizer stake; TIAA-CREF pays $190M for Pfizer building;

@FiercePharma: FDA faces outcry with Avastin breast-cancer choice. Article | Follow @FiercePharma

> Warren Buffett's Berkshire Hathaway gave its stake in Johnson & Johnson a major boost last quarter, while George Soros' hedge fund slashed its Pfizer stake to $4.7 million from $91.4 million. Report | Article

> The pension fund TIAA-CREF has closed on its $190 million purchase of Pfizer's 685 Third Avenue building in New York. News

> The Federal Trade Commission says Novartis would have to stop selling a cataract-surgery drug in order to complete its planned acquisition of eye care company Alcon. FTC release | Item

> Pfizer may acquire a stake in or license drugs from India's Biocon, the Economic Times reports, citing unidentified people. Report

> McKesson, which acts as middleman between drug companies and retailers such as pharmacies and hospitals, could see its margins expand thanks to its technology business and the U.S. healthcare overhaul, Barron's says. Story

> Sigma Pharmaceuticals stock fell the most in a month in Sydney trading after agreeing to sell its drugs unit to South Africa's Aspen Pharmacare. Story

> Now that older people have prescription drug coverage from Medicare, they are using more antibiotics, a new study has found, raising worries about bacterial resistance to the drugs. Article

Biotech News

 @FierceBiotech: PacBio files for $200 million IPO. Article | Follow @FierceBiotech

> Cypress shoots down Ramius offer--again. Report

> Study: Cancer patients benefit from Phase I drugs. Item

> Lilly halts Phase III Alzheimer's program. Story

Biotech Research News

> Bone marrow cells used to repair damage after heart attacks. Report

> Researchers use iPSCs to treat Parkinson's in rodents. Item

> New malaria drug prepping for clinical trials. Article

> Immune cells in fat tissue could explain obesity-diabetes link. Story

> Researchers get $21 million to study HIV. News

Manufacturing News

> Hamburg offers balanced sound bites from China trip. Story

> China a good place to start fight against fake APIs. Report

> India reports change in fakes-distribution tactic. News

> Supplement's "enhancement" drives recall. Article

> Teva axes 70 with propofol exit. Story

And Finally... Diabetics who undergo weight-loss surgery need fewer medications to control the condition and have lower healthcare costs after the procedure, a study found. Report